Mr. Tao Xinhua, chairman of the board of directors of Beijing Leadingpharm Medicine, was co elected as vice president of the medical and pharmaceutical chamber of Commerce of the all China Federation of industry and commerce
On August 7, the 15th president's office meeting of the third session of the medical and pharmaceutical chamber of Commerce of the all China Federation of industry and commerce was successfully held in Nanchang Shangri La Hotel. The meeting was presided over by xiulaigui, President of the all China Federation of industry and Commerce medical and pharmaceutical chamber of Commerce. The president, vice president and Secretary General of the chamber all attended and made speeches.
The meeting first summarized and evaluated the work of the chamber of Commerce in 2020, and adjusted the vice-president of the chamber of commerce according to the requirements of the all China Federation of industry and Commerce on the assessment methods for the leading groups directly under the chamber of Commerce, as well as the governance requirements of the internal personnel of each enterprise. After deliberation and decision, Beijing Leadingpharm Medicine Technology Development Co., Ltd., Jianmin Pharmaceutical Group Co., Ltd. and Jiangsu Kangyuan Pharmaceutical Co., Ltd. were selected as vice president units of the National Federation of industry and Commerce medical and pharmaceutical chamber of Commerce.
Among them, Beijing Leadingpharm Medicine has been recognized as "the president unit of R & D branch and the largest R & D service company of the whole industry chain in China". The Conference unanimously adopted the resolution to elect Mr. Tao Xinhua, the new leading chairman of the board, as the vice president of the National Federation of industry and Commerce of China! At the same time, Beijing Leadingpharm Medicine Technology Development was promoted to vice president of the Federation!
Mr. Tao said that three years ago, The Beijing Leadingpharm Medicine Technology Development was first elected as the president unit of the branch of R & D and service. From scratch, it actively cooperated with many enterprises to complete the consistency evaluation work and established strategic partners with many enterprises. Now, we have more responsibilities, but we have the confidence and ability to do the work better. The Beijing Leadingpharm Medicine never stops making progress, As the vice president of the chamber of Commerce, we always bear in mind the responsibility of "doing practical work and serving the member units". We always have the enterprise vision of "it is I who make China's new drug technology and production process keep pace with the world". In 2020, The Beijing Leadingpharm Medicine Technology Development will actively promote the construction and development of " Beijing Leadingpharm Medicine CXO" system, provide one-stop whole process service for the industry, and comprehensively assist the development of biomedical industry!
Finally, Mr. Tao extended a sincere invitation to you. The Beijing Leadingpharm Medicine will jointly hold " the second Zhengzhou International biopharmaceutical development summit forum" with relevant departments of Henan Province and biological park from September 25 to 27, 2020. At that time, all modules of " Beijing Leadingpharm Medicine CXO" (whole industry chain service outsourcing) will be introduced to you. Here, We sincerely invite colleagues from all walks of life to visit and guide!
轉(zhuǎn)載聲明:未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán),不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:新領(lǐng)先醫(yī)藥科技”。